Cargando…

The Effect of Combination Therapy with Rituximab and Intravenous Immunoglobulin on the Progression of Chronic Antibody Mediated Rejection in Renal Transplant Recipients

The treatment for chronic active antibody-mediated rejection (CAMR) remains controversial. We investigated the efficacy of rituximab (RTX) and intravenous immunoglobulin (IVIg) for CAMR. Eighteen patients with CAMR were treated with RTX (375 mg/m(2)) and IVIg (0.4 g/kg) for 4 days. The efficacy of R...

Descripción completa

Detalles Bibliográficos
Autores principales:	An, Gun Hee, Yun, Jintak, Hong, Yu Ah, Khvan, Marina, Chung, Byung Ha, Choi, Bum Soon, Park, Cheol Whee, Choi, Yeong Jin, Kim, Yong-Soo, Yang, Chul Woo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3987969/ https://www.ncbi.nlm.nih.gov/pubmed/24741626 http://dx.doi.org/10.1155/2014/828732

Ejemplares similares

Clinical Trial of Allogeneic Mesenchymal Stem Cell Therapy for Chronic Active Antibody-Mediated Rejection in Kidney Transplant Recipients Unresponsive to Rituximab and Intravenous Immunoglobulin
por: Ban, Tae Hyun, et al.
Publicado: (2021)

Effects of pretransplant plasmapheresis and rituximab on recurrence of focal segmental glomerulosclerosis in adult renal transplant recipients
por: Park, Hoon Suk, et al.
Publicado: (2014)

Impact of ABO Incompatibility on the Development of Acute Antibody-Mediated Rejection in Kidney Transplant Recipients Presensitized to HLA
por: Chung, Byung Ha, et al.
Publicado: (2015)

Risk factors in the progression of BK virus-associated nephropathy in renal transplant recipients
por: Lee, Hae Min, et al.
Publicado: (2015)

Changing pattern and safety of pretransplant malignancy in kidney transplant recipients
por: Ban, Tae Hyun, et al.
Publicado: (2019)

Clinical significance of the presence of anti-human leukocyte antigen-donor specific antibody in kidney transplant recipients with allograft dysfunction
por: Chung, Byung Ha, et al.
Publicado: (2018)

Profound hyperacute cardiac allograft rejection rescue with biventricular mechanical circulatory support and plasmapheresis, intravenous immunoglobulin, and rituximab therapy
por: Kaczorowski, David J, et al.
Publicado: (2013)

Safety and immunologic benefits of conversion to sirolimus in kidney transplant recipients with long-term exposure to calcineurin inhibitors
por: Yu, Ji Hyun, et al.
Publicado: (2016)

Reversing Autoimmunity Combination of Rituximab and Intravenous Immunoglobulin
por: Ahmed, A. Razzaque, et al.
Publicado: (2018)

Clinical Significance of Pre- and Post-Transplant BAFF Levels in Kidney Transplant Recipients
por: Min, Ji Won, et al.
Publicado: (2016)

Clinical characteristics and outcomes in renal transplant recipients with renal cell carcinoma in the native kidney
por: Sun, In O, et al.
Publicado: (2013)

Effectiveness of Intravenous Immunoglobulin Plus Plasmapheresis on Antibody-mediated Rejection or Thrombotic Microangiopathy in Iranian Kidney Transplant Recipient
por: Dashti-Khavidaki, Simin, et al.
Publicado: (2015)

De novo glomerulitis associated with graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: A single-center experience
por: Cho, Yul Hee, et al.
Publicado: (2013)

Clinical Impact of Pre-transplant Antibodies Against Angiotensin II Type I Receptor and Major Histocompatibility Complex Class I-Related Chain A in Kidney Transplant Patients
por: Min, Ji Won, et al.
Publicado: (2018)

Impact of acute kidney injury in expanded criteria deceased donors on post-transplant clinical outcomes: multicenter cohort study
por: Park, Woo Yeong, et al.
Publicado: (2019)

Experience of Anti-Viral Therapy in Hepatitis B-Associated Membranous Nephropathy, Including Lamivudine-Resistant Strains
por: Sun, In O, et al.
Publicado: (2012)

Rituximab, plasma exchange and immunoglobulins: an ineffective treatment for chronic active antibody-mediated rejection
por: Piñeiro, Gastón J, et al.
Publicado: (2018)

Acute kidney injury with extreme hyperuricemia after antithymocyte globulin treatment in a kidney transplant recipient with underlying aplastic anemia: a case report
por: Park, Yohan, et al.
Publicado: (2020)

Effect of intradialytic change in blood pressure and ultrafiltration volume on the variation in access flow measured by ultrasound dilution
por: Park, Hoon Suk, et al.
Publicado: (2013)

Cytomegalovirus Induced Interstitial Nephritis and Ureteral Stenosis in Renal Transplant Recipient
por: Bae, Sung Ha, et al.
Publicado: (2012)

Clinical significance of the Kidney Donor Profile Index in deceased donors for prediction of post-transplant clinical outcomes: A multicenter cohort study
por: Lee, Jong Hoon, et al.
Publicado: (2018)

Acute kidney injury induced by thrombotic microangiopathy in a patient with hemophagocytic lymphohistiocytosis
por: Bae, Myoung Nam, et al.
Publicado: (2016)

Malignant Hypertension with an Unusual Presentation Mimicking the Immune Mediated Pulmonary Renal Syndrome
por: Park, Hoon Suk, et al.
Publicado: (2012)

Clinical significance of CCR7(+)CD8(+) T cells in kidney transplant recipients with allograft rejection
por: Kim, Kyoung Woon, et al.
Publicado: (2018)

Rejection-triggered haemophagocytic syndrome in renal transplantation successfully treated with intravenous immunoglobulin
por: Marques, Igor Denizarde Bacelar, et al.
Publicado: (2013)

Clinical usefulness of kidney biopsy in liver transplant recipients with renal impairment
por: Lee, Jong Hoon, et al.
Publicado: (2013)

Impact of pretransplant rituximab induction on highly sensitized kidney recipients: comparison with non-rituximab group
por: Song, Young Hae, et al.
Publicado: (2012)

Intravenous immunoglobulin as a therapeutic option for patients with worsening COVID-19 under rituximab
por: Vasconcelos, Joana, et al.
Publicado: (2021)

Predictors of nonresponse to intravenous immunoglobulin therapy in Kawasaki disease
por: Park, Hyo Min, et al.
Publicado: (2013)

Renal infarction associated with low dose intravenous immunoglobulin in a kidney transplant recipient with sepsis: a case report and literature review
por: Choi, Eun Woo, et al.
Publicado: (2021)

Comparison of Estimating Equations for the Prediction of Glomerular Filtration Rate in Kidney Donors before and after Kidney Donation
por: Chung, Byung Ha, et al.
Publicado: (2013)

Clinical significance of red blood cell distribution width in the prediction of mortality in patients on peritoneal dialysis
por: Sun, In O., et al.
Publicado: (2016)

Comparison of Clinical Outcomes by Different Renal Replacement Therapy in Patients with End-Stage Renal Disease Secondary to Lupus Nephritis
por: Kang, Seok-Hui, et al.
Publicado: (2011)

Hyperglycemic Hyperosmolar Syndrome Caused by Steroid Therapy in a Patient with Lupus Nephritis
por: Kang, Seok-Hui, et al.
Publicado: (2011)

Rituximab and intravenous immunoglobulin treatment in PM/Scl antibody-associated disease: case-based review
por: Srikantharajah, Denesh, et al.
Publicado: (2022)

Intravenous immunoglobulin bridging to rituximab in NMDAR encephalitis patients non-responders to first-line treatments
por: Massa, Federico, et al.
Publicado: (2022)

Treatment with plasmapheresis, immunoglobulins and rituximab for chronic-active antibody-mediated rejection in kidney transplantation: Clinical, immunological and pathological results
por: Mella, Alberto, et al.
Publicado: (2018)

Rituximab use in late antibody-mediated rejection
por: Bansal, S. B.
Publicado: (2016)

Clinical outcomes and effects of treatment in older patients with idiopathic membranous nephropathy
por: Kim, Yaeni, et al.
Publicado: (2019)

Phenotypic and Transcriptomic Lymphocytes Changes in Allograft Recipients After Intravenous Immunoglobulin Therapy in Kidney Transplant Recipients
por: Pilon, Caroline, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ssn6li97rm70v6pgt8n0f4gmqm